Exponent Corp (EXPO) Kapitalizatsiyaning foydaga nisbati

Exponent Failure Analysis Associates - EXPO emitenti grafik logotipi

Exponent, Inc. daromadlari sud jarayonlarining chastotasi va ekologik nazoratga yo'naltirilgan davlat xarajatlariga bog'liq. Kompaniyaning P/E koeffitsiyenti tendentsiyasi foydaning joriy bozor qiymatini aks ettiradi, bunda 35.20 joriy parametr qiymati vazifasini bajaradi. Biznes barqarorligi baxtsiz hodisalar tergovidagi benuqson obro' va korporatsiyalarga operatsion xatarlarni kamaytirish uchun logistika yo'nalishlarini optimallashtirishda ko'maklashish orqali ta'minlanadi.

Exponent Corp (EXPO): Narx-foyda koeffitsiyenti 04.07.2022dan 10.11.2026gacha

Exponent, Inc. kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning umumiy tahlili:EXPO, exponent.com
Exponent ishlab chiqargan mahsulot

Huquqiy nizolarda Exponent, Inc. (EXPO) kompaniyasining ilmiy va texnik ekspertizasiga bo‘lgan barqaror talab siklik ta’sirni minimallashtirib, bashorat qilinadigan kapitalizatsiya uchun asos yaratadi. Sof foyda asosidagi P/E koeffitsiyentini tahlil qilish orqali investor bozor qiymatining yillik daromadga nisbati yordamida investitsiyalarning qoplanish muddatini aniqlaydi, bu esa aktivning daromadlariga nisbatan haddan tashqari sotib olinganligi yoki fundamental jihatdan qadrsizlanganligini baholash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

CTAS: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Thomson Reuters Corporation (TRI)|HLI - Kapitalizatsiyaning foydaga nisbati|Booz Allen Hamilton Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori Rentokil Initial Group RTO|EXLS: Narx-foyda koeffitsiyenti|pjtpartners.com - Bozor narxining sof foydaga nisbati|Moelis (MC) - Narxning foydaga nisbati|FCN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Concentrix + Webhelp|Kapitalizatsiyaning foydaga nisbati WNS Corp WNS|Narx-foyda koeffitsiyenti CBZ (CBIZ, Inc.)|P/E multiplikatori abm.com (ABM)|Narxning foydaga nisbati Acuren TIC|Kompaniya qiymatining sof foydaga nisbati LZ|ICF International Inc - P/E multiplikatori|TaskUs Platform (TASK) - Narx-foyda koeffitsiyenti|WLDN: P/E multiplikatori|CRAI - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati TELUS International (Cda) Inc.|Narx-foyda multiplikatori DLX (Deluxe Corp)|P/E multiplikatori PHLT|Hackett Corp (HCKT) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori IBEX (IBEX Ltd)|anpa.com.hk (ANPA) - Kapitalizatsiyaning foydaga nisbati|XRX: Narx-foyda koeffitsiyenti|CNDT (Conduent Inc.) - Narx-foyda multiplikatori|Kingsway Corp (KFS) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati INV (Innventure Group)|Narxning foydaga nisbati Open Lending|Kapitalizatsiyaning foydaga nisbati RCM Tech RCMT|Narxning foydaga nisbati TTEC Holdings, Inc. (TTEC)|rgp.com - Narx-foyda multiplikatori|P/E multiplikatori EGG (Enigmatig)|Team Industrial Services (TISI) - Kapitalizatsiyaning foydaga nisbati|PMEC - Narxning foydaga nisbati|ACCS (ACCESS Newswire Inc) - Narx-foyda multiplikatori|HHS (Harte Hanks) - Narx-foyda koeffitsiyenti|RYOJ: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti SPPL|GRNQ: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori WAI|Biznesning o‘zini qoplash muddati quhuo.cn|Narxning foydaga nisbati Powell Max PMAX|LICN: Narx-foyda multiplikatori|Bluemount - P/E multiplikatori|Zenta Group Co. Ltd (ZGM) - Narx-foyda koeffitsiyenti|FOFO (hfintech.io) - Narx-foyda koeffitsiyenti|ARC - Biznesning o‘zini qoplash muddati|GVP (GSE Systems Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati NV5 Global NVEE|Narx-foyda koeffitsiyenti PFMT (Performant Financial Corp)|sterlingcheck.com - Narx-foyda multiplikatori|Narxning foydaga nisbati TDCX Inc TDCX